Title | Type | SJR | H index | Total Docs. (2008) | Total Docs. (3years) | Total Refs. (2008) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2008) | %Female (2008) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
80 | Current Aging Science | journal | 42 | 27 | 0 | 745 | 0 | 0 | 0.00 | 27.59 | 45.00 | ||
79 | Current Chemical Biology | journal | 26 | 25 | 0 | 3217 | 0 | 0 | 0.00 | 128.68 | 30.00 | ||
78 | Current Clinical Pharmacology | journal | 0.289 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
77 | Current Molecular Pharmacology | journal | 49 | 23 | 0 | 2979 | 0 | 0 | 0.00 | 129.52 | 31.08 | ||
76 | Current Pharmacogenomics and Personalized Medicine | journal | 20 | 26 | 0 | 2826 | 0 | 0 | 0.00 | 108.69 | 31.76 | ||
75 | Current Psychiatry Reviews | journal | 0.320 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
74 | Recent Patents on Drug Delivery and Formulation | journal | 0.246 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
73 | Recent Patents on Endocrine, Metabolic and Immune Drug Discovery | journal | 28 | 25 | 0 | 2328 | 0 | 0 | 0.00 | 93.12 | 37.29 | ||
72 | Recent Patents on Engineering | journal | 21 | 23 | 0 | 1173 | 0 | 0 | 0.00 | 51.00 | 28.33 | ||
71 | Recent Patents on Inflammation and Allergy Drug Discovery | journal | 0.142 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
70 | Open Mechanics Journal | journal | 0.162 Q3 | 7 | 12 | 6 | 270 | 4 | 6 | 0.67 | 22.50 | 0.00 | |
69 | Current Bioinformatics | journal | 0.677 Q2 | 38 | 17 | 12 | 1756 | 18 | 12 | 1.50 | 103.29 | 26.67 | |
68 | Current Bioactive Compounds | journal | 0.201 Q3 | 31 | 25 | 17 | 1887 | 13 | 16 | 0.76 | 75.48 | 19.23 | |
67 | Recent Patents on Biotechnology | journal | 0.267 Q3 | 42 | 23 | 19 | 2213 | 20 | 19 | 1.05 | 96.22 | 25.86 | |
66 | Recent Advances in Drug Delivery and Formulation | journal | 41 | 22 | 22 | 2485 | 19 | 22 | 0.86 | 112.95 | 35.19 | ||
65 | Recent Patents on Nanotechnology | journal | 0.288 Q2 | 36 | 19 | 23 | 1814 | 23 | 23 | 1.00 | 95.47 | 37.14 | |
64 | Current Signal Transduction Therapy | journal | 0.118 Q4 | 22 | 22 | 25 | 3146 | 8 | 25 | 0.32 | 143.00 | 38.98 | |
63 | Recent advances in inflammation & allergy drug discovery | journal | 37 | 27 | 28 | 2069 | 12 | 28 | 0.43 | 76.63 | 28.81 | ||
62 | Current Drug Therapy | journal | 0.259 Q2 | 20 | 20 | 30 | 2194 | 20 | 28 | 0.67 | 109.70 | 29.69 | |
61 | Emirates Journal of Food and Agriculture | journal | 0.110 Q4 | 43 | 14 | 32 | 400 | 3 | 32 | 0.10 | 28.57 | 17.39 | |
60 | Frontiers in Drug Design and Discovery | book series | 0.362 Q2 | 9 | 0 | 41 | 0 | 27 | 39 | 0.66 | 0.00 | 0.00 | |
59 | Recent Patents on CNS Drug Discovery | journal | 0.492 Q2 | 36 | 23 | 47 | 2346 | 75 | 47 | 1.60 | 102.00 | 40.35 | |
58 | Recent Patents on Anti-Cancer Drug Discovery | journal | 0.627 Q2 | 52 | 23 | 49 | 2218 | 112 | 49 | 2.29 | 96.43 | 28.13 | |
57 | Current Reviews in Clinical and Experimental Pharmacology | journal | 49 | 24 | 51 | 1878 | 50 | 51 | 0.98 | 78.25 | 33.33 | ||
56 | Current Computer-Aided Drug Design | journal | 0.361 Q2 | 32 | 30 | 52 | 2612 | 63 | 48 | 1.21 | 87.07 | 24.51 | |
55 | Recent Advances in Anti-Infective Drug Discovery | journal | 38 | 22 | 52 | 1985 | 67 | 52 | 1.29 | 90.23 | 31.58 | ||
54 | Drug Metabolism Letters | journal | 0.154 Q3 | 31 | 48 | 53 | 1355 | 25 | 52 | 0.47 | 28.23 | 35.64 | |
53 | Current Enzyme Inhibition | journal | 0.267 Q3 | 19 | 20 | 54 | 1890 | 42 | 54 | 0.78 | 94.50 | 30.91 | |
52 | Current Immunology Reviews | journal | 0.294 Q3 | 23 | 24 | 56 | 2396 | 31 | 54 | 0.55 | 99.83 | 29.58 | |
51 | Reviews on Recent Clinical Trials | journal | 0.235 Q3 | 35 | 26 | 59 | 2055 | 39 | 55 | 0.66 | 79.04 | 27.40 | |
50 | Current Analytical Chemistry | journal | 0.668 Q2 | 38 | 35 | 60 | 2878 | 91 | 60 | 1.52 | 82.23 | 30.93 | |
49 | Current Pharmaceutical Analysis | journal | 0.420 Q2 | 27 | 27 | 60 | 2132 | 68 | 60 | 1.13 | 78.96 | 49.52 | |
48 | Current Proteomics | journal | 0.333 Q4 | 27 | 24 | 61 | 2092 | 57 | 60 | 0.79 | 87.17 | 23.44 | |
47 | Current Cancer Therapy Reviews | journal | 0.169 Q3 | 17 | 38 | 62 | 3213 | 15 | 60 | 0.24 | 84.55 | 45.05 | |
46 | Current Drug Safety | journal | 0.146 Q3 | 41 | 33 | 63 | 1626 | 27 | 62 | 0.43 | 49.27 | 30.43 | |
45 | Current Organic Synthesis | journal | 1.605 Q1 | 55 | 20 | 65 | 2865 | 201 | 64 | 2.60 | 143.25 | 31.48 | |
44 | Current Cardiology Reviews | journal | 0.235 Q3 | 58 | 37 | 66 | 2988 | 30 | 66 | 0.45 | 80.76 | 17.80 | |
43 | Current Stem Cell Research and Therapy | journal | 0.403 Q2 | 63 | 31 | 70 | 3139 | 132 | 70 | 1.89 | 101.26 | 28.75 | |
42 | Current Drug Discovery Technologies | journal | 0.438 Q3 | 49 | 39 | 71 | 2701 | 139 | 69 | 1.82 | 69.26 | 33.87 | |
41 | Current Medical Imaging | journal | 0.231 Q3 | 37 | 37 | 71 | 1961 | 48 | 65 | 0.68 | 53.00 | 15.53 | |
40 | Current Women's Health Reviews | journal | 0.128 Q3 | 16 | 34 | 71 | 2410 | 16 | 65 | 0.23 | 70.88 | 49.46 | |
39 | Current Nutrition and Food Science | journal | 0.155 Q3 | 32 | 31 | 73 | 2928 | 38 | 68 | 0.52 | 94.45 | 45.16 | |
38 | Current Pediatric Reviews | journal | 0.173 Q3 | 33 | 37 | 73 | 2384 | 26 | 71 | 0.36 | 64.43 | 42.05 | |
37 | Current Nanoscience | journal | 1.043 Q1 | 52 | 51 | 74 | 3269 | 187 | 71 | 2.53 | 64.10 | 28.33 | |
36 | Mini-Reviews in Organic Chemistry | journal | 1.198 Q1 | 43 | 32 | 74 | 2126 | 173 | 74 | 1.88 | 66.44 | 25.00 | |
35 | Anti-Infective Agents | journal | 0.348 Q3 | 26 | 25 | 75 | 2377 | 72 | 70 | 0.85 | 95.08 | 35.63 | |
34 | Central Nervous System Agents in Medicinal Chemistry | journal | 0.261 Q3 | 39 | 30 | 77 | 3787 | 53 | 75 | 0.56 | 126.23 | 42.11 | |
33 | Current Hypertension Reviews | journal | 0.189 Q3 | 27 | 33 | 77 | 2887 | 23 | 77 | 0.30 | 87.48 | 33.33 | |
32 | Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry | journal | 0.189 Q3 | 17 | 48 | 77 | 5042 | 24 | 68 | 0.31 | 105.04 | 33.61 | |
31 | Current Neuropharmacology | journal | 0.467 Q2 | 103 | 26 | 78 | 5205 | 83 | 75 | 1.18 | 200.19 | 19.35 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®